Dihydro-alpha-ergocryptine 0.222 mg / dihydro-beta-ergocryptine 0.111 mg / dihydroergocornine 0.333 mg / dihydroergocristine 0.333 mg Oral Tablet
RxNorm 346959
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 346959 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dihydro-alpha-ergocryptine 0.222 mg / dihydro-beta-ergocryptine 0.111 mg / dihydroergocornine 0.333 mg / dihydroergocristine 0.333 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.